GAS5 is downregulated in NSCLC, and low expression correlates with a poor prognosis, in contrast to oncogenic lncRNAs such as HIT and LUCAT-1 that are upregulated in NSCLC and positively regulate proliferation [48,67,105]. The gene discussed is GAS5; the disease is non-small cell lung carcinoma.